Tempus AI, Inc.

Services-Computer Programming, Data Processing, Etc.

TEMMixed5 of 9 basics passed

$71.05

+2.55%

Market cap $12.9B

$71.05

+2.55%

Market cap $12.9B

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful.

It is a $12.9B technology company. Revenue grew 50.4% over the last year, it currently loses money, and it carries $722M of net debt.

Website: tempus.com
Location: Chicago, IL
Employees: 3 800
Sector: Technology
Founded: 2015

Share price · 2 years

$40.25 → $71.05+76.5%

price only — dividends excluded

Key facts · TTM

Revenue: total sales; $1.43B
Loss: spends more than it earns; -$254M
Free cash flow: cash left after running the business; -$263M
Net debt: debt minus cash on hand; $722M
Shares: down 100% since 2021 — buybacks; 174,264
Volatility: beta vs the market — under 1 swings less; 2.21

Revenue, last 5 years

52-week range

Low $41.55$71.05High $96.39

Today's price is 54% of the way from the year's low to its high.

Valuation vs own history

P/S

9.0×

P/B

28.9×

Share of the last ~5 years that was pricier than today (unusually expensive vs its own history). Based on the daily valuation record.

Insider activity · 90 days

-$17.1Mnet selling

Purchases$0

Sales$17.1M

Insiders trading, last 14d0 buy · 0 sell

Standing in Technology

Size$12.9Btop 74%
Revenue growth+58%top 5%
Net margin-18%top 94%
Return on equity-55%top 97%

Ranked against 220 Technology companies with a full CV — for P/E, lower ranks higher.

Skills

Six independent scores, 0–100, built from reported numbers and valuation history. Click a row to see how it was scored.

Valuation, Growth, Profitability, Health, Quality and Moat lag behind.

Valuation32

P/E vs own historyn/a · 10/25
FCF yield-2.0% · 0/25
P/S8.9x · 12/25
EV/EBITDAn/a · 10/25

Growth25

Revenue CAGR49.0% · 25/25
Net income CAGRn/a · 0/25
EPS CAGR ~5Yn/a · 0/25
Fwd implied growthn/a · 0/25

Profitability0

ROIC-15.6% · 0/25
ROE-54.7% · 0/25
Net margin-17.8% · 0/25
Operating margin-21.4% · 0/25

Health33

Altman Z-0.94 · 3/25
Current ratio3.30 · 25/25
Interest coverage-3.7x · 0/25
Net cash / debtD/A 32% · 5/25

Quality21

Piotroski F5/9 · 15/25
Beneish M-1.44 · 6/25
FCF conversionn/a · 0/25
Margin stabilityσ 45.5% · 0/25

Moat20

ROIC >12% years0/5 yrs · 0/25
Median gross margin53.8% · 20/25
FCF-positive years0/5 yrs · 0/25
Worst-year net marginworst -115.5% · 0/25

How the scores work →

Experience

The company's career so far — founding, the IPO, landmark products and acquisitions, plus revenue milestones and insider buying.

2026Acquisition
Tempus agreed to acquire cancer-testing company Personalis in a deal valued at approximately US$1.5…
FY2025Financial
Revenue crossed $1B
$1.27B for the year
Jun 14, 2024IPO
The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
2015Founded
Tempus AI, Inc. (formerly Tempus Labs) is an American health technology company founded in 2015 by Eric Lefkofsky in…

Achievements

Verifiable track record, straight from the reported numbers.

$1.3B revenue in FY2025

Revenue up 50.4% year over year

3 800 employees

Strengths & watch-outs

What a bull and a bear would each point to. Both lists come from the reported numbers, not opinions.

Strengths

High gross margin (64.0%)
Revenue growing 50.4% year over year

Watch-outs

Not profitable — 17.8% net margin
Negative free cash flow (-$263.2M)
Altman Z-Score -0.94 — elevated financial-distress risk
Thin interest coverage (-3.7×)
Loss-making in 5 of the recent years

Qualifications

The basics a company should meet before you research it further. Each check uses the reported numbers.

5 of 9 checks passed

Revenue growing — the company sells more than a year ago+50.4% YoY
Profitable — makes more than it spends-$254M TTM
Profit growing — earnings are higher than last year+65.3% YoY
Generates cash — cash left after running and investing-$263M TTM
Debt under control — could handle its obligationscurrent ratio 3.30
Established company — not a micro-cap — lower blow-up risk$12.9B market cap
Not printing shares — share count not ballooning — you keep your slice-99.7% shares over ~5y
Proven track record — years of profitability behind it0/5 profitable years
Financially stable — balance sheet not near distressAltman Z -0.9 — distress
Pays a dividend — returns cash to shareholdersno data
Valuation not extreme — price not wildly above earningsno data

Peer comparisonTempus AI, Inc. vs 6 largest technology peers — cap, P/E, growth and margin side by sideOpen ▾

Company	Market cap	P/E	Revenue growth	Net margin	Profile
TEM this company	$12.9B	—	+50.4%	-17.8%	Mixed
NVDA Nvidia Corp	$5.5T	28.6	+83.4%	63.7%	Mixed
AAPL Apple Inc.	$4.9T	38.1	+14.2%	27.6%	Strong
GOOGL Alphabet Inc.	$4.3T	17.6	+20.1%	54.8%	Mixed
MSFT Microsoft Corp	$4.0T	29.7	+17.8%	40.3%	Strong
SPCX Space Exploration Technologies Corp.	$2.1T	—	+33.2%	-34.0%	Strained
META Meta Platforms, Inc.	$1.8T	26.9	+27.7%	29.8%	Mixed

Head-to-head: TEM vs NVDA · TEM vs AAPL · TEM vs GOOGL

References

What covering analysts publish about the company — information only, not a recommendation.

Strong buy 6Buy 7Hold 8Sell 1Strong sell 1

Appendix · Financial records

The full statements behind this CV, FY2021–FY2025. For readers who want to check the numbers.

Profit & lossRevenue $1.43B · net income -$254M (TTM)Open ▾

Profit & loss

Revenue and profit over the company's career — the income statement, visualised.

How FY2025 revenue flows to profit

RevenueNet income

Revenue (TTM)

$1.43B

YoY 50.4%

Net income (TTM)

-$254M

Margin -17.8%

Gross margin

64.0%

Operating margin

-21.4%

Income statement — full detail

Figures in USD billions · EPS in USD

	2021	2022	2023	2024	2025
Revenue	0.3	0.3	0.5	0.7	1.3
Gross profit	0.1	0.1	0.3	0.4	0.8
Operating income (EBIT)	-0.2	-0.3	-0.2	-0.7	-0.3
Net income	-0.3	-0.3	-0.3	-0.7	-0.2
EPS (diluted)	-4.73	-5.28	-4.01	-5889.15	-1406.07

Cash flowFree cash flow -$263M · operating cash flow -$237M (TTM)Open ▾

Cash flow statement

Cash generated by the business and what is left after investment — year by year.

Operating cash flowFree cash flow

Free cash flow (TTM)

-$263M

Margin -18.4%

Operating cash flow (TTM)

-$237M

FCF margin

-18.4%

Cash flow statement — full detail

Figures in USD billions

	2021	2022	2023	2024	2025
Operating cash flow	-0.2	-0.2	-0.2	-0.2	-0.2
Capital expenditure	-0.0	-0.0	-0.0	-0.0	-0.0
Free cash flow	-0.2	-0.2	-0.2	-0.2	-0.2
FCF margin	-86.8%	-58.2%	-46.8%	-30.5%	-18.8%

Balance sheetAssets $2.27B · net debt $722M (FY2025)Open ▾

Balance sheet

How the balance sheet is built — what it owns versus how it is financed.

How $2.27B of assets is financed

78%

22%

Liabilities $1.78B — borrowed moneyEquity $491M — owners' stake

Cash vs debt

Total debt $1.33B − cash $605M = net debt $722M

Cash on hand covers 46% of debt.

Altman Z-Score

-0.94

Distress zone

Interest coverage

-3.7x

EBIT ÷ interest expense

ROE

-54.7%

Profit per $1 of equity

Balance sheet — full detail

Figures in USD billions

	2021	2022	2023	2024	2025
Cash & equivalents	0.3	0.3	0.2	0.3	0.6
Total assets	0.5	0.6	0.6	0.9	2.3
Total liabilities	0.4	0.7	0.8	0.9	1.8
Total debt	0.2	0.4	0.5	0.5	1.3
Equity	0.1	-0.1	-0.3	0.1	0.5
Net debt	-0.0	0.1	0.3	0.1	0.7

Want the live picture — intraday moves, valuation history and full analysis?

Deeper analysis of TEM on PreMarketPrice

Figures are derived from company filings (quarterly values normalised from as-filed year-to-date data where applicable) and may be delayed, restated or incomplete. This page is information, not investment advice. Latest price $71.05 · market cap $12.9B.